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Abstract
Background: Thrombosis following stenosis of arteriovenous fistulae resulting in the loss of
vascular access for hemodialysis is an important complication in patients with chronic renal failure.
Percutaneous transluminal angioplasty is being used more frequently in the treatment of stenosis
aiming at increasing the patency of arteriovenous fistulae.
Objective: To evaluate the primary patency of arteriovenous fistulae following percutaneous
transluminal angioplasty.
Patients and method: Patients submitted to percutaneous transluminal angioplasty in the
Angiology service of Hospital de Base in 2004 were analyzed over an average follow-up of 10
months (2 to 16 months).
Results: A total of 22 angioplasties were performed in 20 fistulae of 19 patients. Of the 19 patients,
one did not complete follow-up and one presented with a rupture of the fistulae. The following
complications occurred in the remaining 18 fistulae, three deaths with two fistulae patent until
death; one exeresis of prosthesis due to infection (53 days after the procedure); two thromboses
(3 and 49 days after the procedure) and four restenosis (3 were submitted to a second angioplasty
and one treated surgically). At the end of the follow-up, 11 fistulae (55%) were patent and with a
flow rate in hemodialysis > 300 mL/min. Primary patency was 82.4% over three months; 81.2% over
six months; 54.5% over 9 months and 50% over 1 year.
Conclusion: Percutaneous transluminal angioplasty is an efficacious method for the correction of
stenosis of arteriovenous fistulae for hemodialysis, prolonging the patency of the fistula and
enabling new interventions.
Introduction
The increase in the prevalence of patients with chronic
renal failure on hemodialysis has made several measures
to maintain the vascular access patent and efficacious nec-
essary as, the morbimortality of these patients is directly
related to the effectiveness of hemodialysis. This requires
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rapid blood flow of adequate volume [1-3].
Thrombosis is the most frequent complication of arterio-
venous fistulae that results in the loss of the access for
hemodialysis. Most episodes of thrombosis coincide with
the development of stenosis (in more than 85% of cases),
generally located in the venous segment proximal to the
arteriovenous anastomosis [4-6]. Stenosis in the arterial
segment has been studied less but also compromises the
patency of the vascular access, as well as resulting in
ischemia of the limb and thus should be systematically
investigated and identified in the dialytic population, gen-
erally composed of elderly patients with comorbidities,
many of whom with generalized arterial disease[2,5]. A
small percentage of the thrombosis is caused by hypoten-
sion, unintentional extrinsic pressure, trauma or infection
[3].
Clinically, some findings may be suggestive of stenosis of
the arteriovenous fistula such as the presence of segmental
dilation along the route of the vein or its disappearance,
persistent edema of the limb and the presence of a pulse
without fremitis. Other indicators are evidenced by alter-
ations during hemodialysis, such as inefficacious dialysis,
low blood flow, increase in the venous pressure, difficulty
to obtain another venous access, increase in the time nec-
essary to reach hemostasis after hemodialysis, increase in
the intra-access pressure and signs of recirculation. Thus,
when diagnosed, intervention is justified to maintain the
patency of the vascular access and consequently reduce
the incidence of hemodialysis failure due to loss of the fis-
tula [3,6,7].
Percutaneous transluminal angioplasty is a method that
has proved to be efficacious in the treatment of stenosis to
prolong the endurance of the fistulae [1,2].
The objective of the current study was to evaluate the pri-
mary patency of arteriovenous fistulae after percutaneous
transluminal angioplasty.
Patients and method
A total of 22 angioplasties of 20 fistulae in 19 patients (12
men and 7 women) with a mean age of 53.7 years (range
35 to 75 years) and on hemodialysis for chronic renal fail-
ure were analyzed. The angioplasties were performed in
the angiology service of Hospital de Base in São José do
Rio Preto between January 1 and December 31 2004.
The indications for angiographic studies of the arteriov-
enous fistula were based on clinical criteria or alterations
detected during hemodialysis. The criteria utilized were an
existent pulse but without fremitis, persistent edema of
the limb with the fistula, the presence of constrictions
and/or dilations on the route of the fistula, difficulty to
insert the needles or hemostasis after their removal, blood
flow at the access of less than 200 mL/min, increase in
venous pressure and following thrombectomy surgery.
The angiographic technique employed in all cases was by
venous puncture or puncturing the prosthesis using a 21
needle, the injection of contrast and obtaining digital ang-
iographic images from the arteriovenous anastomosis up
to the central veins. If significant stenosis was present,
angioplasty was performed immediately (Figure 1 and 2).
The angioplasties were performed in all cases by proximal
catheterization of the fistulae with the insertion of intro-
ductory sheaths (varying from 5 to 8 Fr) and regional anti-
coagulation using 2000 IU of heparin. The vessel was
opened using a 0.35 mm × 260 cm hydrophilic guide wire
(Terumo®) and dilated using a balloon catheter (Power-
flex®, Ultra-thin Diamond®) with a diameter 1 mm greater
than the normal size of the venous segment (varying from
4 to 8 mm). The balloon was maintained insufflated for
60 seconds and repeated when necessary using the pres-
sure recommended by the manufacturer.
Results
In the study period, 22 angioplasties were performed in
20 fistulae of 19 patients. Of these fistulae, 18 were with
the cephalic or basilic veins and 2 with polytetrafluor-
oethylene (PTFE) prostheses.
Angiographic study showing proximal stenosis at the anasto-mosis of t e PTFE prosthesis and the axillary veinFigure 1
Angiographic study showing proximal stenosis at the 
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the follow-up in the service after the angioplasty and one
presented a rupture of the arteriovenous fistula during the
procedure and was successfully submitted to surgical cor-
rection with implantation of a PTFE prosthesis.
The other 18 fistulae were evaluated after the procedure
with a mean follow-up of 10 months (Range: 2 to 16
months). Of these, 17 fistulae presented a clinical follow-
up of more than 3 months, 16 more than 6 months, 11
more than 9 months and 8 more than one year.
In this period, there were three deaths not related to the
arteriovenous fistulae or the procedure, of which two were
patients up to their deaths (120 and 289 days after the
angioplasty) and one presented with thrombosis after 40
days and peritoneal dialysis was initiated.
One of the patients, 53 days after the angioplasty, pre-
sented with thrombosis of the fistula and was submitted
to a thrombectomy with angioplasty, however he pre-
sented with an infection in the PTFE prosthesis which
needed to be removed. In two other patients, thrombosis
occurred with loss of the fistulae (with 3 and 49 post-pro-
cedure days).
During the follow-up, 4 cases of restenosis were diag-
nosed. Of these, 3 were submitted to a second angioplasty
resulting in patent fistulae with flow rates for hemodialy-
sis greater than 350 mL/min. One restenosis was surgi-
cally treated with the implantation of a PTFE prosthesis
due to severe stenosis at multiple sites along the route of
the vein (basilic).
At the end of the follow-up period, 11 fistulae were patent
(11/20; 55%), with flow for hemodialysis greater than
300 mL/min.
The primary patency of the 18 fistulae evaluated after
angioplasty was 82.35% over 3 months (14/17); 81.2% at
6 months (13/16); 54.5% at 9 months (6/11) and 50%
over 1 year (4/8).
Discussion
The current study shows that angioplasty is an efficacious
method for the correction of stenosis of arteriovenous fis-
tulae for hemodialysis and constitutes another therapeu-
tic option. In the past, surgical treatment performing
correction of the stenotic lesion using a bypass or a patch
was the only option [3].
In recent years, several studies have demonstrated that
angioplasty is efficacious with some advantages compared
to the conventional surgical treatment such as a shorter
time needed to perform the procedure and shorter hospi-
talization, less discomfort for the patient, and lower infec-
tion rates. Additionally, it enables dialysis immediately
after the procedure without the necessity of using a central
venous catheter [1-8].
Complications of angioplasty have been reported in
about 2 to 16% of cases, with the most common being
immediate venous rupture during the procedure, the for-
mation of pseudoaneurysms, acute thrombosis and
periprocedural bacteremia. Reaction to the contrast has
not implicated a higher mortality rate of these patients
[3,5]. In this study, 2 complications (9%) occurred: 1
venous rupture which was successfully treated by surgery
and 1 case of acute thrombosis with loss of the fistula
three days after angioplasty.
The literature shows that primary patency at 12 months
after angioplasty is equivalent of surgical treatment [1].
The current study confirms these findings and suggests
this therapeutic approach as another possible option for
stenosis of arteriovenous fistulae.
Conclusion
Angioplasty is efficacious in the correction of stenosis of
fistulae for hemodialysis, increasing the survival rate of
the fistula and allowing more interventions.
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